PBMD

Prima BioMed Ltd Press Releases

$1.08
*  
unch
unch
Get PBMD Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading PBMD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PBMD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Japanese Patent Grants for IMP321 in Cancer
5/1/2016 8:00:00 PM - Marketwired
unchange Price Change since this news event. The Volume Ratio is 2.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




IMP321 Safety and Immune Monitoring Data Published in Clinical Cancer Research Journal
3/15/2016 3:40:00 AM - Marketwired
▲13.68 % Price Change since this news event. The Volume Ratio is 0.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency
3/4/2016 1:32:00 AM - Marketwired
▲27.06 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologic in EU Clinical Trial
3/2/2016 1:05:00 AM - Marketwired
▲30.12 % Price Change since this news event. The Volume Ratio is 1.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day